Immune landscape and biomarkers for immuno-oncology in colorectal cancers
Recent advances in immuno-oncology have increased understanding of the tumor immune microenvironment (TIME), and clinical trials for immune checkpoint inhibitor treatment have shown remission and/or durable response in certain proportions of patients stratified by predictive biomarkers. The TIME in...
Saved in:
Main Authors: | Jeong Mo Bae (Author), Seung-Yeon Yoo (Author), Jung Ho Kim (Author), Gyeong Hoon Kang (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
by: Jung Ho Kim, et al.
Published: (2015) -
Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
by: Seung-Yeon Yoo, et al.
Published: (2019) -
A comparative prognostic performance of definitions of Crohn-like lymphoid reaction in colorectal carcinoma
by: Younghoon Kim, et al.
Published: (2021) -
Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
by: Hyeon Jeong Oh, et al.
Published: (2017) -
Prognostic Impact of Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
by: Hyeon Jeong Oh, et al.
Published: (2019)